Harvard Bioscience Inc financial data

Symbol
HBIO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
84 October Hill Rd, Holliston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 196 % -14.5%
Quick Ratio 101 % -13.3%
Debt-to-equity 90.2 % -7.56%
Return On Equity -15.1 % -104%
Return On Assets -7.92 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.6M shares +2.16%
Common Stock, Shares, Outstanding 43.6M shares +2.16%
Entity Public Float 219M USD +54.7%
Common Stock, Value, Issued 436K USD -4.6%
Weighted Average Number of Shares Outstanding, Basic 43.5M shares +2.67%
Weighted Average Number of Shares Outstanding, Diluted 43.5M shares +2.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 101M USD -11.4%
Research and Development Expense 11.4M USD -0.39%
Selling and Marketing Expense 23.3M USD -2.81%
General and Administrative Expense 22.7M USD -4.74%
Operating Income (Loss) -5M USD -199%
Nonoperating Income (Expense) -4.43M USD +7.69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.43M USD -45.7%
Income Tax Expense (Benefit) 1.25M USD +68.4%
Net Income (Loss) Attributable to Parent -10.7M USD -96.7%
Earnings Per Share, Basic -0.25 USD/shares -92.3%
Earnings Per Share, Diluted -0.25 USD/shares -92.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.05M USD -6.38%
Accounts Receivable, after Allowance for Credit Loss, Current 12.5M USD -26.1%
Inventory, Net 25.1M USD -3.68%
Other Assets, Current 4.77M USD -10.1%
Assets, Current 46.4M USD -11.8%
Deferred Income Tax Assets, Net 436K USD +30.9%
Property, Plant and Equipment, Net 4.76M USD +36.3%
Operating Lease, Right-of-Use Asset 4.42M USD -15.9%
Intangible Assets, Net (Excluding Goodwill) 13.4M USD -26.8%
Goodwill 56.6M USD -0.25%
Other Assets, Noncurrent 3.24M USD -49.5%
Assets 129M USD -9.79%
Accounts Payable, Current 5.71M USD +21.1%
Employee-related Liabilities, Current 2.38M USD -37.2%
Contract with Customer, Liability, Current 4.01M USD +4.56%
Liabilities, Current 22.6M USD -1.4%
Deferred Income Tax Liabilities, Net 764K USD +14.5%
Operating Lease, Liability, Noncurrent 4.71M USD +1.29%
Other Liabilities, Noncurrent 1.61M USD +53.6%
Liabilities 61.7M USD -8.66%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14.9M USD -5.79%
Retained Earnings (Accumulated Deficit) -153M USD -7.49%
Stockholders' Equity Attributable to Parent 67.2M USD -10.8%
Liabilities and Equity 129M USD -9.79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.4M USD -22.6%
Net Cash Provided by (Used in) Financing Activities -1.06M USD +63.5%
Net Cash Provided by (Used in) Investing Activities -225K USD -178%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 43.6M shares +2.16%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28K USD +96.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 768K USD -34.5%
Deferred Tax Assets, Valuation Allowance 15.2M USD +4.94%
Deferred Tax Assets, Gross 22.5M USD -2.23%
Operating Lease, Liability 5.77M USD -14.9%
Depreciation 404K USD +21.3%
Payments to Acquire Property, Plant, and Equipment 645K USD +188%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.5M USD -84.2%
Lessee, Operating Lease, Liability, to be Paid 7.54M USD -16.7%
Property, Plant and Equipment, Gross 18.4M USD +0.85%
Operating Lease, Liability, Current 1.06M USD -50.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.18M USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.28M USD +18.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.77M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.14M USD +3.83%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.22M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.12M USD +6.59%
Operating Lease, Payments 597K USD -8.58%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.41M USD -9.48%
Deferred Tax Assets, Net of Valuation Allowance 7.29M USD -14.4%
Share-based Payment Arrangement, Expense 5M USD +13.4%